|
Volumn 349, Issue , 2014, Pages g5161-
|
WHO gives go ahead for experimental treatments to be used in Ebola outbreak
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
EBOLA VACCINE;
MONOCLONAL ANTIBODY;
ZMAPP;
AFRICA;
COMPASSIONATE USE;
ETHICS;
HEMORRHAGIC FEVER, EBOLA;
HUMAN;
HUMAN EXPERIMENT;
WORLD HEALTH ORGANIZATION;
AFRICA;
ANTIBODIES, MONOCLONAL;
ANTIVIRAL AGENTS;
COMPASSIONATE USE TRIALS;
EBOLA VACCINES;
HEMORRHAGIC FEVER, EBOLA;
HUMAN EXPERIMENTATION;
HUMANS;
WORLD HEALTH ORGANIZATION;
|
EID: 84908521422
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.g5161 Document Type: Note |
Times cited : (18)
|
References (0)
|